ABCA7
Phospholipid-transporting ATPase ABCA7
Also known as: ABCA7_HUMAN, ABCX
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZY2
- Gene
- ABCA7
- Ensembl
- ENSG00000064687
- Chromosome
- 19
- Canonical length
- 2146 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus,Plasma membrane,Cell Junctions
OverviewNCBI Gene
The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This full transporter has been detected predominantly in myelo-lymphatic tissues with the highest expression in peripheral leukocytes, thymus, spleen, and bone marrow. The function of this protein is not yet known; however, the expression pattern suggests a role in lipid homeostasis in cells of the immune system. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
2146 residues, UniProt reviewed canonical sequence.
>Q8IZY2|ABCA7
1 MAFWTQLMLL LWKNFMYRRR QPVQLLVELL WPLFLFFILV AVRHSHPPLE HHECHFPNKP
61 LPSAGTVPWL QGLICNVNNT CFPQLTPGEE PGRLSNFNDS LVSRLLADAR TVLGGASAHR
121 TLAGLGKLIA TLRAARSTAQ PQPTKQSPLE PPMLDVAELL TSLLRTESLG LALGQAQEPL
181 HSLLEAAEDL AQELLALRSL VELRALLQRP RGTSGPLELL SEALCSVRGP SSTVGPSLNW
241 YEASDLMELV GQEPESALPD SSLSPACSEL IGALDSHPLS RLLWRRLKPL ILGKLLFAPD
301 TPFTRKLMAQ VNRTFEELTL LRDVREVWEM LGPRIFTFMN DSSNVAMLQR LLQMQDEGRR
361 QPRPGGRDHM EALRSFLDPG SGGYSWQDAH ADVGHLVGTL GRVTECLSLD KLEAAPSEAA
421 LVSRALQLLA EHRFWAGVVF LGPEDSSDPT EHPTPDLGPG HVRIKIRMDI DVVTRTNKIR
481 DRFWDPGPAA DPLTDLRYVW GGFVYLQDLV ERAAVRVLSG ANPRAGLYLQ QMPYPCYVDD
541 VFLRVLSRSL PLFLTLAWIY SVTLTVKAVV REKETRLRDT MRAMGLSRAV LWLGWFLSCL
601 GPFLLSAALL VLVLKLGDIL PYSHPGVVFL FLAAFAVATV TQSFLLSAFF SRANLAAACG
661 GLAYFSLYLP YVLCVAWRDR LPAGGRVAAS LLSPVAFGFG CESLALLEEQ GEGAQWHNVG
721 TRPTADVFSL AQVSGLLLLD AALYGLATWY LEAVCPGQYG IPEPWNFPFR RSYWCGPRPP
781 KSPAPCPTPL DPKVLVEEAP PGLSPGVSVR SLEKRFPGSP QPALRGLSLD FYQGHITAFL
841 GHNGAGKTTT LSILSGLFPP SGGSAFILGH DVRSSMAAIR PHLGVCPQYN VLFDMLTVDE
901 HVWFYGRLKG LSAAVVGPEQ DRLLQDVGLV SKQSVQTRHL SGGMQRKLSV AIAFVGGSQV
961 VILDEPTAGV DPASRRGIWE LLLKYREGRT LILSTHHLDE AELLGDRVAV VAGGRLCCCG
1021 SPLFLRRHLG SGYYLTLVKA RLPLTTNEKA DTDMEGSVDT RQEKKNGSQG SRVGTPQLLA
1081 LVQHWVPGAR LVEELPHELV LVLPYTGAHD GSFATLFREL DTRLAELRLT GYGISDTSLE
1141 EIFLKVVEEC AADTDMEDGS CGQHLCTGIA GLDVTLRLKM PPQETALENG EPAGSAPETD
1201 QGSGPDAVGR VQGWALTRQQ LQALLLKRFL LARRSRRGLF AQIVLPALFV GLALVFSLIV
1261 PPFGHYPALR LSPTMYGAQV SFFSEDAPGD PGRARLLEAL LQEAGLEEPP VQHSSHRFSA
1321 PEVPAEVAKV LASGNWTPES PSPACQCSRP GARRLLPDCP AAAGGPPPPQ AVTGSGEVVQ
1381 NLTGRNLSDF LVKTYPRLVR QGLKTKKWVN EVRYGGFSLG GRDPGLPSGQ ELGRSVEELW
1441 ALLSPLPGGA LDRVLKNLTA WAHSLDAQDS LKIWFNNKGW HSMVAFVNRA SNAILRAHLP
1501 PGPARHAHSI TTLNHPLNLT KEQLSEGALM ASSVDVLVSI CVVFAMSFVP ASFTLVLIEE
1561 RVTRAKHLQL MGGLSPTLYW LGNFLWDMCN YLVPACIVVL IFLAFQQRAY VAPANLPALL
1621 LLLLLYGWSI TPLMYPASFF FSVPSTAYVV LTCINLFIGI NGSMATFVLE LFSDQKLQEV
1681 SRILKQVFLI FPHFCLGRGL IDMVRNQAMA DAFERLGDRQ FQSPLRWEVV GKNLLAMVIQ
1741 GPLFLLFTLL LQHRSQLLPQ PRVRSLPLLG EEDEDVARER ERVVQGATQG DVLVLRNLTK
1801 VYRGQRMPAV DRLCLGIPPG ECFGLLGVNG AGKTSTFRMV TGDTLASRGE AVLAGHSVAR
1861 EPSAAHLSMG YCPQSDAIFE LLTGREHLEL LARLRGVPEA QVAQTAGSGL ARLGLSWYAD
1921 RPAGTYSGGN KRKLATALAL VGDPAVVFLD EPTTGMDPSA RRFLWNSLLA VVREGRSVML
1981 TSHSMEECEA LCSRLAIMVN GRFRCLGSPQ HLKGRFAAGH TLTLRVPAAR SQPAAAFVAA
2041 EFPGAELREA HGGRLRFQLP PGGRCALARV FGELAVHGAE HGVEDFSVSQ TMLEEVFLYF
2101 SKDQGKDEDT EEQKEAGVGV DPAPGLQHPK RVSQFLDDPS TAETVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABCA7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 15
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 49 nTPM
- spleen: 42 nTPM
- bone marrow: 26 nTPM
- retina: 24 nTPM
- cerebellum: 17 nTPM
- small intestine: 16 nTPM
Single-cell type
- extravillous trophoblasts: 474 nCPM
- rod photoreceptor cells: 380 nCPM
- cone photoreceptor cells: 290 nCPM
- retinal bipolar cells: 235 nCPM
- alveolar cells type 1: 108 nCPM
- neutrophils: 108 nCPM
Immune cell
- plasmacytoid DC: 7.3 nTPM
- eosinophil: 6 nTPM
- neutrophil: 3.3 nTPM
- basophil: 2.8 nTPM
- myeloid DC: 2.1 nTPM
- gdT-cell: 1.8 nTPM
Brain region
- choroid plexus: 23 nTPM
- cerebral cortex: 11 nTPM
- medulla oblongata: 11 nTPM
- pons: 11 nTPM
- midbrain: 8.1 nTPM
- thalamus: 7.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ABCA7.
Disease | AllUniProt
Conditions ABCA7 is implicated in, by any mechanism.
- Alzheimer disease 9 (AD9) MIM:608907
Disease | GeneticClinVar
24 pathogenic / likely-pathogenic of 566 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Alzheimer disease 9
- ABCA7-related disorder
- Clear cell carcinoma of kidney
- Sarcoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.47
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amyloid-beta clearance by cellular catabolic process
- amyloid-beta formation
- apolipoprotein A-I-mediated signaling pathway
- cholesterol efflux
- high-density lipoprotein particle assembly
- memory
- negative regulation of amyloid precursor protein biosynthetic process
- negative regulation of amyloid-beta formation
- negative regulation of endocytosis
- negative regulation of MAPK cascade
- negative regulation of PERK-mediated unfolded protein response
- phagocytosis
- phospholipid efflux
- phospholipid translocation
- plasma membrane raft organization
- positive regulation of amyloid-beta clearance
- positive regulation of cholesterol efflux
- positive regulation of engulfment of apoptotic cell
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of phagocytosis
- positive regulation of phospholipid efflux
- positive regulation of protein localization to cell surface
- protein localization to nucleus
- regulation of amyloid precursor protein catabolic process
- regulation of lipid metabolic process
- visual learning
Molecular functions
- ABC-type transporter activity
- apolipoprotein A-I receptor activity
- ATP binding
- ATP hydrolysis activity
- ATPase-coupled transmembrane transporter activity
- floppase activity
- phosphatidylcholine floppase activity
- phosphatidylserine floppase activity
- phospholipid transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ABC transporter-like, ATP-binding domain
- AAA+ ATPase domain
- ABC-2 type transporter, transmembrane domain
- ABC transporter-like, conserved site
- ABC transporter A
- P-loop containing nucleoside triphosphate hydrolase
- ABCA1-4-like, C-terminal R2 regulatory domain
- ABC transporter
- ABC-2 family transporter protein
- ABCA1-like, C-terminal R1 regulatory domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABCA7 as an antibody target. Whether an autoantibody or antibody against ABCA7 could matter depends on whether native ABCA7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABCA7 is annotated at the cell surface, where native ABCA7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ABCA7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...